Article
San Francisco - New melanoma staging criteria will be "vitallyimportant" for assigning patients into various risk categories as awider variety of adjuvant therapies become available, according to CharlesM. Balch, M.D.
The Weekly Roundup: October 7-11
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Safe and Effective: Upadacitinib Shows Promise in PN Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial